首页 | 本学科首页   官方微博 | 高级检索  
     

CXCR4和CXCR7在肿瘤中的研究进展
引用本文:邱明远,李健文,郑民华. CXCR4和CXCR7在肿瘤中的研究进展[J]. 中国癌症杂志, 2010, 20(3): 222-226
作者姓名:邱明远  李健文  郑民华
作者单位:上海交通大学医学院附属瑞金医院普外科,上海市微创外科临床医学中心,上海,200025
摘    要:以往的研究认为趋化因子受体4(chemokine receptor 4,CXCR4)是趋化因子CXCL12的唯一受体,CXCL12/CXCR4生物轴在肿瘤发展过程中起重要作用,然而最近研究发现CXCL12尚存在CXCR7这一新的受体,并且CXCL12/CXCR7生物轴同样对肿瘤的发生发展起重要作用.本文就有关趋化因子受体CXCR4和CXCR7在肿瘤中的表达、促进肿瘤增殖和转移、促进血管新生以及肿瘤治疗等方面的研究作一综述.

关 键 词:肿瘤  趋化因子受体

The chemokine receptors CXCR4 and CXCR7 in cancer
QIU Ming-yuan,LI Jian-wen,ZHENG Min-hua. The chemokine receptors CXCR4 and CXCR7 in cancer[J]. China Oncology, 2010, 20(3): 222-226
Authors:QIU Ming-yuan  LI Jian-wen  ZHENG Min-hua
Affiliation:QIU Ming-yuan,LI Jian-wen,ZHENG Minhua(Department of General Surgery,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai Minimally Invasive Surgery Center,Shanghai 200025,China)
Abstract:CXCR4 has long been considered as the unique receptor of CXCL12,and CXCL12/CXCR4 axis plays a prominent role in tumorigenesis.However,a novel receptor for CXCL12,named CXCR7,has been recently identified and also plays an important role in tumorigenesis.This review summarized current studies regarding the functions of CXCR4 and CXCR7 in cancer and the recent therapeutic approaches that target these receptors or their ligands.
Keywords:CXCR4  CXCR7  CXCL12  CXCR4  CXCR7  CXCL12  cancer  chemokine receptor
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号